AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Intro
This chapter explores the partnership between Life Biosciences and Forge Biologics in the development of a partial epigenetic reprogramming therapy. It underscores the significance of choosing the right contract development and manufacturing organization (CDMO) while providing insights into Forge Biologics' strategic growth in the cell and gene therapy industry.